Abstract
In this article, we want to present the reader with an interesting clinical case from authors’ practice, which, in our opinion, clearly demonstrates the efficacy and safety of using Gliatilin (choline alfoscerate) as a part of combination therapy in a 19-year-old man with so-called «long COVID syndrome», manifesting itself predominantly as mix of symptoms of asthenia, depression, anxiety, sleep and cognitive difficulties. This patient, for his ideological reasons and beliefs, refused taking antidepressants, anxiolytics, as well as any other psychotropic drugs. At the same time, the patient asked for help in choosing «a treatment, which will consist of only natural ingredients».
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.